BioCentury
ARTICLE | Clinical News

Cobiprostone: Development discontinued

July 18, 2016 7:00 AM UTC

Sucampo discontinued development of cobiprostone following a pre-specified futility analysis of a double-blind, U.S. Phase IIa trial evaluating an oral spray formulation of cobiprostone in about 180 p...